Alternatives
Alternatives to Bupivacaine 133 mg/10 mL liposomal injectable suspension
1 other presentations of Bupivacaine 133 mg/10 mL liposomal injectable suspension
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Bupivacaine), strength (133 mg/10 mL) and dosage form (liposomal injectable suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Bupivacaine 133 mg/10 mL liposomal injectable suspensionThis pageInfiltration | — | US FDA | 10 vials of 10 mL | Cold chain | On request | — | Available on request |
| Exparel 133 mg/10 mL liposomal injectable suspensionInfiltration | Pacira Pharmaceuticals | US FDA | 4 vials of 10 mL, 10 vials of 10 mL | — | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Bupivacaine 133 mg/10 mL liposomal injectable suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.